TOPIC 313 PHASE I; RNAI CANCER THERAPEUTICS USING NANOTECHNOLOGY; HHSN2612013000

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: N43CA130030
Agency Tracking Number: N43CA130030
Amount: $200,000.00
Phase: Phase I
Program: SBIR
Awards Year: 2013
Solicitation Year: 2013
Solicitation Topic Code: NCI
Solicitation Number: N/A
Small Business Information
GENESEGUES, INC., 3180 HIGH POINT DRIVE, CHASKA, MN, 55318-9476
DUNS: 95972415
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 GRETCHEN UNGER
 (952) 443-3798
 GMU@GENESEGUES.COM
Business Contact
 GRETCHEN UNGER
Phone: (952) 443-3798
Email: GMU@GENESEGUES.COM
Research Institution
 Stub
Abstract
The design, fabrication, characterization, and preclinical evaluation of novel nanoparticle-based drug formulations capable of delivering candidate RNAi therapeutics for the treatment of cancer. PUBLIC HEALTH RELEVANCE

* Information listed above is at the time of submission. *

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government